Clinical trials

  • Pembrolizumab for Stage IIB melanoma | Stage IIC melanoma
  • RIBOCICLIB for Hormone receptor positive HER2-negative early breast cancer
  • Precemtabart tocentecan for Pancreatic ductal adenocarcinoma | Metastatic pancreatic carcinoma
  • DURVALUMAB for Hepatocellular carcinoma
  • Ravulizumab for Delayed graft function after kidney transplantation
  • BNT327 for Small cell lung cancer (extensive-stage)
  • AZD9793 for Hepatocellular carcinoma
  • BNT327 (bispecific antibody against vascular endothelial growth factor A and programmed death-ligand 1) for Non-small cell lung cancer
  • SELGANTOLIMOD for Chronic hepatitis B
  • TILDRAKIZUMAB for Genital psoriasis | Plaque psoriasis
  • Rotigotine for Autosomal dominant polycystic kidney disease
  • LY3372993 for Alzheimer's disease